Lingwen Ying

1.0k total citations · 1 hit paper
26 papers, 729 citations indexed

About

Lingwen Ying is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Lingwen Ying has authored 26 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Lingwen Ying's work include Diabetes Management and Research (13 papers), Diabetes and associated disorders (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Lingwen Ying is often cited by papers focused on Diabetes Management and Research (13 papers), Diabetes and associated disorders (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Lingwen Ying collaborates with scholars based in China, India and United States. Lingwen Ying's co-authors include Jian Zhou, Yuqian Bao, Xiaojing Ma, Wei Zhu, Weiping Jia, Jingyi Lu, Wei Lu, Yifei Mo, Lei Zhang and Robert A. Vigersky and has published in prestigious journals such as Diabetes Care, Scientific Reports and British Journal Of Nutrition.

In The Last Decade

Lingwen Ying

26 papers receiving 713 citations

Hit Papers

Association of Time in Range, as Assessed by Continuous G... 2018 2026 2020 2023 2018 100 200 300

Peers

Lingwen Ying
R. W. Bilous United Kingdom
Kyoil Suh South Korea
Mansi Dalal United States
J. Cassar United Kingdom
Myung Hi Yoo South Korea
Jane Fogarty Ireland
Ko Hanai Japan
R. W. Bilous United Kingdom
Lingwen Ying
Citations per year, relative to Lingwen Ying Lingwen Ying (= 1×) peers R. W. Bilous

Countries citing papers authored by Lingwen Ying

Since Specialization
Citations

This map shows the geographic impact of Lingwen Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingwen Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingwen Ying more than expected).

Fields of papers citing papers by Lingwen Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingwen Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingwen Ying. The network helps show where Lingwen Ying may publish in the future.

Co-authorship network of co-authors of Lingwen Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Lingwen Ying. A scholar is included among the top collaborators of Lingwen Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingwen Ying. Lingwen Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ying, Lingwen, Fan Yang, Xin Li, et al.. (2024). Screening/diagnosis of pediatric endocrine disorders through the artificial intelligence model in different language settings. European Journal of Pediatrics. 183(6). 2655–2661. 5 indexed citations
2.
Chang, Guoying, Lingwen Ying, Ruen Yao, et al.. (2024). Genetic variants of ABCC8 and clinical manifestations in eight Chinese children with hyperinsulinemic hypoglycemia. BMC Endocrine Disorders. 24(1). 8–8. 2 indexed citations
3.
Ying, Lingwen, Yun Shen, Yang Zhang, et al.. (2021). Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 177. 108880–108880. 24 indexed citations
4.
Ying, Lingwen, Yun Shen, Yang Zhang, et al.. (2021). Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus. Frontiers in Cardiovascular Medicine. 8. 696156–696156. 7 indexed citations
5.
Ying, Lingwen, et al.. (2021). Macrophage LAMTOR1 Deficiency Prevents Dietary Obesity and Insulin Resistance Through Inflammation-Induced Energy Expenditure. Frontiers in Cell and Developmental Biology. 9. 672032–672032. 8 indexed citations
6.
Ying, Lingwen, Yong Zhang, Yufei Wang, et al.. (2021). Classic Type 1 Diabetes Mellitus and Fulminant Type 1 Diabetes Mellitus: Similarity and Discrepancy of Immunological Characteristics and Cytokine Profile. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4661–4670. 3 indexed citations
7.
Ying, Lingwen, Xiaojing Ma, Yun Shen, et al.. (2020). Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus. Journal of Diabetes Research. 2020. 1–8. 7 indexed citations
8.
Li, Sichen, Yuan Shi, Peixi Liu, et al.. (2020). Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway. Journal of Neuroinflammation. 17(1). 191–191. 43 indexed citations
9.
Ma, Xiaojing, Yun Shen, Xingxing He, et al.. (2019). 1,5-Anhydroglucitol × glycated hemoglobin A1c/100 as a potential biomarker for islet β-cell function among patients with type 2 diabetes. Acta Diabetologica. 57(4). 439–446. 5 indexed citations
10.
Ying, Lingwen, Xiaojing Ma, Jingyi Lu, et al.. (2019). Fulminant type 1 diabetes: The clinical and continuous glucose monitoring characteristics in Chinese patients. Clinical and Experimental Pharmacology and Physiology. 46(9). 806–812. 11 indexed citations
11.
Tang, Junling, Xiaojing Ma, Xingxing He, et al.. (2018). Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population. Journal of Diabetes Research. 2018. 1–7. 5 indexed citations
12.
Ying, Lingwen, Xiaojing Ma, Jun Yin, et al.. (2018). The metabolism and transport of 1,5-anhydroglucitol in cells. Acta Diabetologica. 55(3). 279–286. 21 indexed citations
13.
He, Xingxing, Yifei Mo, Xiaojing Ma, et al.. (2018). Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A 1c ratio in Chinese diabetic and non-diabetic populations. Clinica Chimica Acta. 484. 117–121. 21 indexed citations
14.
Lu, Jingyi, Xiaojing Ma, Jian Zhou, et al.. (2018). Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care. 41(11). 2370–2376. 355 indexed citations breakdown →
15.
Peng, Jiahui, Jingyi Lu, Xiaojing Ma, et al.. (2018). Breakfast replacement with a liquid formula improves glycaemic variability in patients with type 2 diabetes: a randomised clinical trial. British Journal Of Nutrition. 121(5). 560–566. 12 indexed citations
16.
Ying, Lingwen, Xingxing He, Xiaojing Ma, et al.. (2017). Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population. Scientific Reports. 7(1). 11968–11968. 26 indexed citations
17.
Wang, Yufei, Xiaojing Ma, Xingxing He, et al.. (2017). Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test. International Journal of Endocrinology. 2017. 1–8. 7 indexed citations
18.
19.
He, Xingxing, Lingwen Ying, Xiaojing Ma, et al.. (2017). An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population. Clinica Chimica Acta. 475. 188–192. 10 indexed citations
20.
He, Xingxing, Xiang Hu, Xiaojing Ma, et al.. (2017). Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus. Cardiovascular Diabetology. 16(1). 77–77. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026